“Oncaspar” for the treatment of acute lymphoblastic leukemia is included in the CHI program
The drug for children with acute lymphoblastic leukemia "Oncaspar" is included in the program for compulsory health insurance (CMI). This...
The drug for children with acute lymphoblastic leukemia "Oncaspar" is included in the program for compulsory health insurance (CMI). This...
In Russia, there is a shortage of oncaspar, a vital and non-alternative drug for the treatment of children with acute...